Stay updated on Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial
Sign up to get notified when there's something new on the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page.

Latest updates to the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page
- Check5 days agoChange DetectedA banner announces an NIH website transition and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check12 days agoChange DetectedThe footer's site revision identifier changed from v3.7.1 to v3.7.2, while the page continues to display a 403 error.SummaryDifference0.2%

- Check19 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check40 days agoChange DetectedThe study record URL now displays a 403 Forbidden error page, replacing the usual study details content. This indicates restricted access to the record rather than changes to the study data.SummaryDifference18%

- Check61 days agoChange DetectedA minor software revision was applied, updating the page metadata from Revision: v3.6.5 to Revision: v3.6.6. The update does not alter study content or visible functionality.SummaryDifference0.1%

- Check82 days agoChange DetectedPage revision updated from v3.6.4 to v3.6.5, indicating a site version update. No user-visible changes to study details or navigation are evident.SummaryDifference0.1%

Stay in the know with updates to Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page.